Literature DB >> 27060768

Studying human disease using human neurons.

Tim Ahfeldt1, Nadia K Litterman1, Lee L Rubin2.   

Abstract

Utilizing patient derived cells has enormous promise for discovering new drugs for diseases of the nervous system, a goal that has been historically quite challenging. In this review, we will outline the potential of human stem cell derived neuron models for assessing therapeutics and high-throughput screening and compare to more traditional drug discovery strategies. We summarize recent successes of the approach and discuss special considerations for developing human stem cell based assays. New technologies, such as genome editing, offer improvements to help overcome the challenges that remain. Finally, human neurons derived from patient cells have advantages for translational research beyond drug screening as they can also be used to identify individual efficacy and safety prior to clinical testing and for dissecting disease mechanisms. This article is part of a Special Issue entitled SI: Exploiting human neurons.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Drug discovery; Human neurodegenerative disease; Stem cells

Mesh:

Year:  2016        PMID: 27060768      PMCID: PMC5053850          DOI: 10.1016/j.brainres.2016.03.051

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  98 in total

1.  Special issue on CNS experimental medicine.

Authors:  Gerard R Dawson; Colin T Dourish; Guy M Goodwin
Journal:  J Psychopharmacol       Date:  2011-09       Impact factor: 4.153

Review 2.  Translational research in central nervous system drug discovery.

Authors:  Orest Hurko; John L Ryan
Journal:  NeuroRx       Date:  2005-10

3.  Compounds with species and cell type specific toxicity identified in a 2000 compound drug screen of neural stem cells and rat mixed cortical neurons.

Authors:  Nasir Malik; Anastasia G Efthymiou; Karly Mather; Nathaniel Chester; Xiantao Wang; Avindra Nath; Mahendra S Rao; Joseph P Steiner
Journal:  Neurotoxicology       Date:  2014-10-22       Impact factor: 4.294

Review 4.  Screening technologies for small molecule discovery: the state of the art.

Authors:  William P Janzen
Journal:  Chem Biol       Date:  2014-09-18

Review 5.  High-throughput functional genomics using CRISPR-Cas9.

Authors:  Ophir Shalem; Neville E Sanjana; Feng Zhang
Journal:  Nat Rev Genet       Date:  2015-04-09       Impact factor: 53.242

6.  Highly efficient endogenous human gene correction using designed zinc-finger nucleases.

Authors:  Fyodor D Urnov; Jeffrey C Miller; Ya-Li Lee; Christian M Beausejour; Jeremy M Rock; Sheldon Augustus; Andrew C Jamieson; Matthew H Porteus; Philip D Gregory; Michael C Holmes
Journal:  Nature       Date:  2005-04-03       Impact factor: 49.962

7.  Small-Molecule-Driven Direct Reprogramming of Mouse Fibroblasts into Functional Neurons.

Authors:  Xiang Li; Xiaohan Zuo; Junzhan Jing; Yantao Ma; Jiaming Wang; Defang Liu; Jialiang Zhu; Xiaomin Du; Liang Xiong; Yuanyuan Du; Jun Xu; Xiong Xiao; Jinlin Wang; Zhen Chai; Yang Zhao; Hongkui Deng
Journal:  Cell Stem Cell       Date:  2015-08-06       Impact factor: 24.633

8.  Genetic correction of a LRRK2 mutation in human iPSCs links parkinsonian neurodegeneration to ERK-dependent changes in gene expression.

Authors:  Peter Reinhardt; Benjamin Schmid; Lena F Burbulla; David C Schöndorf; Lydia Wagner; Michael Glatza; Susanne Höing; Gunnar Hargus; Susanna A Heck; Ashutosh Dhingra; Guangming Wu; Stephan Müller; Kathrin Brockmann; Torsten Kluba; Martina Maisel; Rejko Krüger; Daniela Berg; Yaroslav Tsytsyura; Cora S Thiel; Olympia-Ekaterini Psathaki; Jürgen Klingauf; Tanja Kuhlmann; Marlene Klewin; Heiko Müller; Thomas Gasser; Hans R Schöler; Jared Sterneckert
Journal:  Cell Stem Cell       Date:  2013-03-07       Impact factor: 24.633

Review 9.  Back and forth in time: Directing age in iPSC-derived lineages.

Authors:  Daniela Cornacchia; Lorenz Studer
Journal:  Brain Res       Date:  2015-11-17       Impact factor: 3.252

10.  Enhanced efficiency of human pluripotent stem cell genome editing through replacing TALENs with CRISPRs.

Authors:  Qiurong Ding; Stephanie N Regan; Yulei Xia; Leoníe A Oostrom; Chad A Cowan; Kiran Musunuru
Journal:  Cell Stem Cell       Date:  2013-04-04       Impact factor: 24.633

View more
  3 in total

Review 1.  Targeting NMDA receptors in neuropsychiatric disorders by drug screening on human neurons derived from pluripotent stem cells.

Authors:  Wenbo Zhang; P Joel Ross; James Ellis; Michael W Salter
Journal:  Transl Psychiatry       Date:  2022-06-09       Impact factor: 7.989

2.  Rapid Neuronal Differentiation of Induced Pluripotent Stem Cells for Measuring Network Activity on Micro-electrode Arrays.

Authors:  Monica Frega; Sebastianus H C van Gestel; Katrin Linda; Jori van der Raadt; Jason Keller; Jon-Ruben Van Rhijn; Dirk Schubert; Cornelis A Albers; Nael Nadif Kasri
Journal:  J Vis Exp       Date:  2017-01-08       Impact factor: 1.355

3.  Hindbrain V2a Neurons Pattern Rhythmic Activity of Motor Neurons in a Reticulospinal Coculture.

Authors:  Adele Bubnys; Hagar Kandel; Lee Ming Kao; Donald Pfaff; Inna Tabansky
Journal:  Front Neurosci       Date:  2019-10-17       Impact factor: 4.677

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.